Rentokil Initial (RKLIF) Cash & Equivalents (2020 - 2025)

Rentokil Initial (RKLIF) has 6 years of Cash & Equivalents data on file, last reported at $1.4 billion in Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $1.4 billion, up 17.08% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.4 billion (up 17.08% YoY), and the FY2025 annual result was $1.4 billion, up 39.42% from the prior year.
• Cash & Equivalents rose to $1.4 billion in Q4 2025 per RKLIF's latest filing, from $6.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $1.9 billion in Q4 2023 and troughed at $6.0 million in Q3 2025.
• A 5-year average of $853.2 million and a median of $896.5 million in 2021 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents slumped 61.78% in 2022, then jumped 583.0% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $742.8 million in 2021, then tumbled by 61.78% to $283.8 million in 2022, then jumped by 583.0% to $1.9 billion in 2023, then plunged by 38.76% to $1.2 billion in 2024, then advanced by 17.08% to $1.4 billion in 2025.
• Business Quant data shows RKLIF's Cash & Equivalents at $1.4 billion in Q4 2025, $6.0 million in Q3 2025, and $467.0 million in Q2 2025.